GE Healthcare has received FDA clearance for its new software application, PET VCAR (Volume Computer-Assisted Reading), designed to help clinicians diagnose, stage, treat and monitor tumors and other lesions in the body. The software will be showcased at the Society of Nuclear Medicine (SNM) annual conference, June 2-6, in Washington, D.C.

The FDA clearance includes a GE-patented Interactive Data Analysis (IDA) tool, which allows physicians to systematically track treatment over time and quantitatively interpret a patient’s response to therapy. The new IDA capability facilitates decision-making by automating several previously manual processes and presenting data in an organized, user-configurable format, GE said.  

“The Interactive Data Analysis feature provides a tumor report card allowing physicians to systematically visualize, analyze and manage tumors over time with unparalleled efficiency. We believe PET VCAR will help improve the clinicians’ daily reading experience and patient management,” said Kelly Piacsek, PhD, global oncology product manager.